Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus
Background Rituximab appears to be effective for treating pemphigus, although there are limited long-term data. Methods This retrospective single-center study evaluated patients with conventional treatment-resistant pemphigus who received rituximab during September 2010–December 2019. The first ritu...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-05-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09546634.2021.1919288 |